These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27489636)

  • 1. Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling.
    Mokuda S; Kanno M; Takasugi K; Okumura C; Ito Y; Masumoto J
    SAGE Open Med Case Rep; 2014; 2():2050313X13519774. PubMed ID: 27489636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.
    Tran AP; Edelman J
    Int J Rheum Dis; 2011 Aug; 14(3):e33-7. PubMed ID: 21816011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.
    Tausche AK; Wunderlich C; Aringer M
    Case Rep Med; 2011; 2011():397646. PubMed ID: 21629805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An elderly man presenting polyarthritis diagnosed as chronic tophaceous gout].
    Sugiura M; Aoki A
    Nihon Ronen Igakkai Zasshi; 2015; 52(4):415-20. PubMed ID: 26700782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout.
    Marotto D; De Santis A; Chessa D; Firinu D; Del Giacco S
    Rheumatol Ther; 2018 Jun; 5(1):303-310. PubMed ID: 29524120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septic polyarthritis in chronic tophaceous gout.
    Salvi A; Rossi M; Balestrieri GP; di Stefano O; Baratto G; Giustina G
    Recenti Prog Med; 1991 Oct; 82(10):527-8. PubMed ID: 1759037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of chronic tophaceous with a continuous polyarthritis and joint deformity caused by uncontrolled hyperuricemia].
    Kawashiri S; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Ichinose K; Kamachi M; Tamai M; Nakamura H; Ida H; Origuchi T; Eguchi K
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Jun; 31(3):190-4. PubMed ID: 18587231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra in resistant gout: a case report.
    Van Wabeke J; Dhondt E; Peene I; Piette Y
    Acta Clin Belg; 2017 Aug; 72(4):293-295. PubMed ID: 27712511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.
    Solomon DH; Glynn RJ; MacFadyen JG; Libby P; Thuren T; Everett BM; Ridker PM
    Ann Intern Med; 2018 Oct; 169(8):535-542. PubMed ID: 30242335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation.
    Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL
    Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic tophaceous gout with unusual large tophi: case report.
    Aradoini N; Talbi S; Berrada K; Abourazzak FZ; Harzy T
    Pan Afr Med J; 2015; 22():132. PubMed ID: 26889313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tophaceous gout of the spine mimicking epidural infection: case report and review of the literature.
    Barrett K; Miller ML; Wilson JT
    Neurosurgery; 2001 May; 48(5):1170-2; discussion 1172-3. PubMed ID: 11334288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent response to the clinical treatment of tophaceous gout.
    Caldas CA; Fuller R
    Clin Rheumatol; 2007 Sep; 26(9):1553-5. PubMed ID: 17047891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current opinions on gout, its diagnosis and treatment].
    Němec P
    Vnitr Lek; 2012 Dec; 58(12):928-37. PubMed ID: 23427951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab in a patient with tophaceous gout resistant to treatment.
    Pinto JL; Mora GE; Fernández-Avila DG; Gutiérrez JM; Díaz MC;
    Reumatol Clin; 2013; 9(3):178-80. PubMed ID: 23122521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-1 inhibitors in the management of gout.
    Tran TH; Pham JT; Shafeeq H; Manigault KR; Arya V
    Pharmacotherapy; 2013 Jul; 33(7):744-53. PubMed ID: 23553601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.
    Lu CC; Wu SK; Chen HY; Chung WS; Lee MC; Yeh CJ
    J Rheumatol; 2014 Sep; 41(9):1878-83. PubMed ID: 25086077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol.
    Richette P; Bardin T
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):338-42; quiz 343. PubMed ID: 16932713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?
    Schreiner O; Wandel E; Himmelsbach F; Galle PR; Märker-Hermann E
    Nephrol Dial Transplant; 2000 May; 15(5):644-9. PubMed ID: 10809805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tophaceous gout of the lumbar spine in a patient without systemic gout or normouricaemia].
    Lorente A; Lorente R; Romero J
    Neurocirugia (Astur); 2017; 28(5):242-246. PubMed ID: 28438457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.